| Authors: |
Veletic I; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. iveletic@mdanderson.org., Harris DM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Rozovski U; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petah Tikva, Israel., Bertilaccio MTS; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Calin GA; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Takahashi K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Li P; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Liu Z; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Manshouri T; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Drula RC; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Furudate K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Muftuoglu M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hossain A; Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wierda WG; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Keating MJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Estrov Z; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. zestrov@mdanderson.org. |
